YaoGeJu

Company directoryChina company filings

JIANGSU YONGAN PHARMACEUTICAL CO., LTD

As of 18 November 2026, for the company name JIANGSU YONGAN PHARMACEUTICAL CO., LTD as recorded, the chemical-drug catalogue lists 6 active records with this name as holder; 20 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

19 acceptance records as first applicant, grouped into 13 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Ilaprazole Enteric-coated Tablets 1 records · Latest accepted 2026/07/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601826Generic2026/07/29JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
缬沙坦左氨氯地平片 · No verified English name 1 records · Latest accepted 2026/06/04

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2600078New drug2026/06/04JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
氨氯地平缬沙坦氢氯噻嗪片 · No verified English name 1 records · Latest accepted 2026/05/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2600063Generic2026/05/20JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Cinitapride Hydrogen Tartrate Tablets 1 records · Latest accepted 2025/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503191Generic2025/08/30JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sacubitril Valsartan Sodium Tablets 2 records · Latest accepted 2025/08/02

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502778Generic2025/08/02JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
CYHS2502777Generic2025/08/02JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Iguratimod Tablets 1 records · Latest accepted 2025/07/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502366Generic2025/07/04JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Valsartan and Amlodipine Tablets 1 records · Latest accepted 2025/02/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500304Supplement2025/02/18JIANGSU YONGAN PHARMACEUTICAL CO., LTD; Beijing Bai Ao Pharma Co., Ltd. romanizedCDE ↗
Diacerein Capsules 1 records · Latest accepted 2025/01/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500345Generic2025/01/17JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Esomeprazole Magnesium for Delayed-release Oral Suspension 3 records · Latest accepted 2024/12/21

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402186Supplement2024/12/21JIANGSU YONGAN PHARMACEUTICAL CO., LTD; Qingdao Bai Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2402185Supplement2024/12/21JIANGSU YONGAN PHARMACEUTICAL CO., LTD; Qingdao Bai Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2402184Supplement2024/12/21JIANGSU YONGAN PHARMACEUTICAL CO., LTD; Qingdao Bai Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2024/11/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403931Generic2024/11/15JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Edoxaban Tosilate Tablets 3 records · Latest accepted 2024/11/05

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401808Supplement2024/11/05JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
CYHB2401807Supplement2024/11/05JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
CYHB2401806Supplement2024/11/05JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Silodosin Capsules 1 records · Latest accepted 2024/11/05

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401805Supplement2024/11/05JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2024/08/03

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402484Generic2024/08/03JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
CYHS2402483Generic2024/08/03JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

6 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Ilaprazole Enteric-coated Tablets CYHS2601826Generic2026/07/29JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
缬沙坦左氨氯地平片 · No verified English name CXHS2600078New drug2026/06/04JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Cinitapride Hydrogen Tartrate Tablets CYHS2503191Generic2025/08/30JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2502778Generic2025/08/02JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2502777Generic2025/08/02JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Iguratimod Tablets CYHS2502366Generic2025/07/04JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗

Catalogue holder records

6 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Diacerein CapsulesJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202651362026/07/08Generic approved under the new chemical-drug registration classificationCDE ↗
Azilsartan Medoxomil Potassium TabletsJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202557862025/10/21Generic approved under the new chemical-drug registration classificationCDE ↗
Azilsartan Medoxomil Potassium TabletsJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202557872025/10/21Generic approved under the new chemical-drug registration classificationCDE ↗
Edoxaban Tosilate TabletsJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202533562025/02/08Generic approved under the new chemical-drug registration classificationCDE ↗
Edoxaban Tosilate TabletsJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202533552025/02/08Generic approved under the new chemical-drug registration classificationCDE ↗
Edoxaban Tosilate TabletsJIANGSU YONGAN PHARMACEUTICAL CO., LTDJIANGSU YONGAN PHARMACEUTICAL CO., LTD国药准字H202533572025/02/08Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
二甲基亚砜 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20250001149I2026/01/15CDE ↗
盐酸咪达普利 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20230001053A2025/03/19CDE ↗
盐酸咪达普利 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20230000629I2024/07/17CDE ↗
磷酸森格列汀 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20220000899A2026/06/02CDE ↗
米拉贝隆 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20210000956A2024/10/29CDE ↗
枸橼酸铁 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20210000618I2021/08/23CDE ↗
替格瑞洛 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20210000078A2022/10/14CDE ↗
阿普米司特 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20200001330A2024/05/12CDE ↗
盐酸奥普力农 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20200000924A2026/09/15CDE ↗
特立氟胺 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20200000028A2026/08/25CDE ↗
盐酸伊伐布雷定 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20180000746A2025/09/06CDE ↗
氨基己酸 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20190005075A2025/07/18CDE ↗
枸橼酸托法替布 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20190000549A2026/08/06CDE ↗
盐酸西那卡塞 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20180000745A2025/09/16CDE ↗
富马酸替诺福韦二吡呋酯 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20180000513I2019/05/28CDE ↗
枸橼酸托法替布 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20190000332A2023/11/21CDE ↗
甲磺酸多拉司琼 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20190000150I2019/03/29CDE ↗
索磷布韦 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20170002119A2024/10/24CDE ↗
硫酸锰 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20170001648I—CDE ↗
氯化铬 · No verified English nameJIANGSU YONGAN PHARMACEUTICAL CO., LTDY20170001646I—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

37 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Azilsartan Medoxomil Potassium Tablets CYHB2601296Supplement2026/07/09Liaoning Fu Yuan Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHB2601295Supplement2026/07/09Liaoning Fu Yuan Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Cinitapride Hydrogen Tartrate Tablets CYHB2601257Supplement2026/07/03Hainan Hai He Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
醋酸去氨加压素片 · No verified English name CYHS2600975Generic2026/04/28Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
醋酸去氨加压素片 · No verified English name CYHS2600974Generic2026/04/28Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets CYHB2600835Supplement2026/04/28Jin Yao Da Ren Tang Group Co., Ltd. Xin Xin Pharmaceutical Factory romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Iguratimod Tablets CYHB2600508Supplement2026/03/13Yunpeng Pharmaceutical Group Co., Ltd.; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Pentoxifylline Modified Release Tablets CYHS2600403Generic2026/02/07Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Vonoprazan Fumarate Tablets CYHS2600362Generic2026/02/04Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Vonoprazan Fumarate Tablets CYHS2600361Generic2026/02/04Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2503078Generic2025/08/22Jiangxi Yuan Sheng Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2503077Generic2025/08/22Jiangxi Yuan Sheng Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2502254Generic2025/06/23Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2502252Generic2025/06/23Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Ezetimibe and Simvastatin Tablets CYHS2502166Generic2025/06/18Anhui Jia He Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Indobufen Tablets CYHS2500177Generic2025/01/09Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sildenafil Citrate Tablets CYHS2404448Generic2024/12/21Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sildenafil Citrate Tablets CYHS2404447Generic2024/12/21Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Sildenafil Citrate Tablets CYHS2404446Generic2024/12/21Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
醋酸去氨加压素片 · No verified English name CYHS2403504Generic2024/10/17Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
醋酸去氨加压素片 · No verified English name CYHS2403503Generic2024/10/17Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Tadalafil Tablets CYHS2402854Generic2024/08/31Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Tadalafil Tablets CYHS2402853Generic2024/08/31Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Tadalafil Tablets CYHS2402852Generic2024/08/31Guangdong Pei Jie Drug Research Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Epalrestat Tablets CYHS2402661Generic2024/08/15Beijing Sheng Yong Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
二甲双胍恩格列净片(I) · No verified English name CYHS2401814Generic2024/06/18Beijing Sheng Yong Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Amlodipine Besylate Tablets CYHS2400822Generic2024/03/13Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Amlodipine Besylate Tablets CYHS2400821Generic2024/03/13Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Mecobalamin Tablets CYHS2400797Generic2024/03/08Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Perindopril arginine and amlodipine besylate tablets CYHS2302862Generic2023/10/24Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Perindopril Arginine and Amlodipine Besylate Tablets(III) CYHS2302861Generic2023/10/24Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Edoxaban Tosilate Tablets CYHS2302698Generic2023/10/11Beijing Bai Ao Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Edoxaban Tosilate Tablets CYHS2302697Generic2023/10/11Beijing Bai Ao Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Edoxaban Tosilate Tablets CYHS2302696Generic2023/10/11Beijing Bai Ao Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Pentoxifylline Modified Release Tablets CYHS2302475Generic2023/09/13Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Hydrotalcite Chewable Tablets CYHS2302099Generic2023/08/12Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗
Silodosin Capsules CYHS2301420Generic2023/05/25Beijing Bai Ao Pharma Co., Ltd. romanized; JIANGSU YONGAN PHARMACEUTICAL CO., LTDCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.